RSV
GSK’s Arexvy Vaccine Poised for Blockbuster Sales, Besting Pfizer in RSV Market Debut
Pfizer is facing not only a decline in its COVID-19 vaccine sales but also stiff competition from GSK in the ...
GSK’s RSV vaccine poised for label expansion after trial success
Five months after GSK made history by securing FDA approval for its respiratory syncytial virus (RSV) vaccine, Arexvy, the company ...
GSK Teams Up With Ex-Basketball Star To Raise Awareness Of RSV, A Deadly Virus For Babies
GSK is intensifying its campaign to raise awareness about respiratory syncytial virus (RSV) and promote its RSV vaccine, Arexvy. The ...
Pfizer’s Abrysvo Achieves Landmark as First Maternal RSV Vaccine to Safeguard Newborns
Pfizer’s Abrysvo has achieved a groundbreaking milestone by becoming the first vaccine to safeguard newborns against respiratory syncytial virus (RSV) ...
GSK’s Arexvy Takes Lead in RSV Vaccine Race, Now Accessible at Leading US Pharmacies
In the competitive landscape of the respiratory syncytial virus (RSV) vaccine market, GlaxoSmithKline (GSK) stands out with its well-timed strides. ...
Beyfortus: A Breakthrough RSV Shot for Infants Approved by CDC
Source – Sanofi The US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has given ...
GSK lowers short-term hopes for RSV treatment Arexvy but raises 2023 forecast
Great expectations surround GSK’s entry into the respiratory syncytial virus (RSV) vaccine market with their upcoming shot, Arexvy, set to ...
The pipeline for RSV, influenza, meningitis, and pneumococcal disease vaccines raises the bar
Source – Sanofi On June 29, 2023, Sanofi is hosting an investor event focused on its Vaccines pipeline, featuring key ...
FDA Advisory Committee Unanimously Recommends Nirsevimab for Preventing RSV Lower Respiratory Tract Disease in Infants
Source: AstraZeneca The FDA’s Antimicrobial Drugs Advisory Committee (AMDAC) has voted unanimously, with a 21 to 0 decision, affirming the ...
GSK Secures First Approval for RSV Vaccine in EU
The European Commission has given the green light for GSK’s Arexvy to be used in older adults aged 60 or ...
Pfizer’s RSV Vaccine ABRYSVO: A Breakthrough for the Industry and RSV Prevention
Pfizer’s RSV Vaccine: In a groundbreaking development, Pfizer’s FDA approval for its RSV vaccine, ABRYSVO, has not only positioned the ...
FDA Grants Approval to ABRYSVO, Pfizer’s Vaccine for Preventing Respiratory Syncytial Virus (RSV) in Elderly Individuals
The FDA, on May 31, 2023, granted approval to ABRYSVO (Respiratory Syncytial Virus Vaccine), Pfizer’s bivalent RSV prefusion F (RSVpreF) ...
